Growth Metrics

Biocryst Pharmaceuticals (BCRX) Retained Earnings: 2010-2014

Historic Retained Earnings for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to -$467.9 million.

  • Biocryst Pharmaceuticals' Retained Earnings fell 8.01% to -$492.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$492.8 million, marking a year-over-year decrease of 8.01%. This contributed to the annual value of -$467.9 million for FY2014, which is 10.69% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Retained Earnings of -$467.9 million as of FY2014, which was down 10.69% from -$422.7 million recorded in FY2013.
  • Biocryst Pharmaceuticals' Retained Earnings' 5-year high stood at -$296.6 million during FY2010, with a 5-year trough of -$467.9 million in FY2014.
  • Moreover, its 3-year median value for Retained Earnings was -$422.7 million (2013), whereas its average is -$427.7 million.
  • Data for Biocryst Pharmaceuticals' Retained Earnings shows a maximum YoY fell of 19.20% (in 2011) over the last 5 years.
  • Over the past 5 years, Biocryst Pharmaceuticals' Retained Earnings (Yearly) stood at -$296.6 million in 2010, then declined by 19.20% to -$353.5 million in 2011, then fell by 11.05% to -$392.6 million in 2012, then decreased by 7.67% to -$422.7 million in 2013, then decreased by 10.69% to -$467.9 million in 2014.